Evolution of the Treatments for Hemophilia.

Guelcher, Christine J

Guelcher, Christine J.

Affiliation

Guelcher CJ; Hemostasis and Thrombosis Program, Center for Cancer and Blood Disorders, Children's National Health System, Washington, DC. Christine J. Guelcher, MS, APRN, PPCNP-BC, is a program coordinator in the hemostasis and thrombosis program at the Center for Cancer and Blood Disorders of the Children's National Health System in Washington, DC. She currently serves as secretary on the Board of the American Thrombosis and Hemostasis Network (ATHN). She serves as the nurse liaison and ad hoc member on the

J Infus Nurs ; 39(4): 218-24, 2016.

Article in En | MEDLINE | ID: mdl-27379680

Subject(s)

Factor IX/therapeutic use; Factor VIII/therapeutic use; Hemophilia A/drug therapy; Hemophilia A/history; Hemophilia B/drug therapy; Hemophilia B/history; Catheterization, Peripheral/methods; Factor IX/immunology; Factor VIII/immunology; Hemophilia A/complications; Hemophilia A/immunology; Hemophilia B/complications; Hemophilia B/immunology; Hemorrhage/etiology; Hemorrhage/therapy; History, 19th Century; History, Ancient; Humans; Infusions, Intravenous; Male; Mutation/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor IX / Factor VIII / Hemophilia B / Hemophilia A Type of study: Etiology_studies Limits: Humans / Male Language: En Journal: J Infus Nurs Journal subject: ENFERMAGEM Year: 2016 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google